NOVOBONE GRANULES 3g - 1000-2000 micron
Ref NBG-8
Active
CE MDR
Valid until
27 Nov 2028
FDA recalls
Not applicable
Documents
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR | NumberCSQ0015230226 | Date8 Jun 2026 | StatusActive |
Certificates
- CSQ0015230226 Active
Quality management system EU MDR
- Certifier
- ISTITUTO SUPERIORE DI SANITA' 0373
- Issued
- 8 Jun 2026
- Expires
- 27 Nov 2028
- Reason
- Add device or group
- CVD0021230226 Active
Technical documentation EU MDR
- Certifier
- ISTITUTO SUPERIORE DI SANITA' 0373
- Issued
- 8 Jun 2026
- Expires
- 27 Nov 2028
- Reason
- Add device or group
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/MDR Active
Specification
- Device Name
- Novobone Granules
- Model / Reference
- NBG-8
- Primary DI / UDI-DI
- 08053847158160
- Basic UDI-DI
- 805228249BOVINENOVOBONE5G
- Direct Marketing DI
- 08053847158160
- EMDN Code
- P900401 Bone and tendon replacement devices
- Device Class
- Class III
- EU market of registration
- Türkiye
Manufacturer details
- EUDAMED SRN
- IT-MF-000028342
Other devices from B. & B. Dental S.r.l.
Properties
Other properties (10)
- Reusable: No
- Contains Latex: No
- Reprocessed: No
- CMR Substance: No
- Human-derived: No
- Human Tissues: No
- Endocrine Disruptor: No
- Administering Medicine: No
- Measuring Function: No
- Incorporates Medicinal Product: No